source:[1] Wave Life Sciences (WVE) Stock on December 11, 2025: Obesity Breakthrough, 180% Rally, $350M Offering and Fresh Analyst Targets - ts2.tech (https://ts2.tech/en/wave-life-sciences-wve-st ...)[2] Pfizer's $2bn+ obesity bet, and other weight-loss news - pharmaphorum (https://pharmaphorum.com/news/pfizers-2bn-obe ...)[3] Lilly's obesity triple threat smashes efficacy expectations in phase 3 but proves intolerable for some - Fierce Biotech (https://www.fiercebiotech.com/biotech/eli-lil ...)